Expertise and experience
Specialized expertise combined with high patient volumes drive superior results at Mayo Clinic. In a typical year, Mayo Clinic providers see nearly 4,000 individual patients for multiple myeloma across all phases of treatment and continuing care, and over 400 patients receive peripheral blood stem cell transplant for multiple myeloma at Mayo Clinic in Rochester, Minnesota, Phoenix and Scottsdale, Arizona, and Jacksonville, Florida. Each year, the Rochester campus of Mayo Clinic alone sees approximately 500 new patients for multiple myeloma care. Mayo Clinic also has broad expertise across the spectrum of disease related to myeloma, including monoclonal gammopathy, smoldering multiple myeloma, amyloidosis, POEMS syndrome and Castleman disease.
Patients seen annually for multiple myeloma at Mayo Clinic in Rochester, Minnesota, Phoenix and Scottsdale, Arizona, and Jacksonville, Florida
- Nearly 4,000 patients seen for multiple myeloma
- 400+ peripheral blood stem cell transplants for multiple myeloma
- Approximately 500 new patients seen for multiple myeloma in Rochester, Minnesota
Minimal disruption to your life
We strive to provide world-class care with minimal disruption to your life. Mayo Clinic is a pioneer in performing outpatient peripheral blood stem cell transplant for multiple myeloma, a care model that can reduce cost and burden. Our autologous transplant program in Rochester, Minnesota, was established in 1989.
Outcomes from peripheral blood stem cell transplant for multiple myeloma at Mayo Clinic in Rochester, Minnesota
- 0 days median inpatient hospital length of stay
- 25% of patients age 75 or younger requiring inpatient hospital stay 5 days or more
- 0.3% day-100 all-cause mortality
- Gertz MA, et al. Safety outcomes for autologous stem cell transplant in multiple myeloma. Mayo Clinic Proceedings. 2018; doi:10.1016/J.MAYOCP.2017.09.012.
Results that show in patient ratings
Patient satisfaction with Mayo Clinic is very high. Among patients with an outpatient office visit at Mayo Clinic for a diagnosis of multiple myeloma, 99% of survey respondents* gave Mayo Clinic the top or next-to-top rating when it came to reporting on overall satisfaction with care, likelihood of recommending Mayo Clinic and other key experience questions.
Good or very good (top two ratings) from respondents with an office visit for multiple myeloma†
*Surveys administered by Press Ganey
†Diagnosis of multiple myeloma accompanying 2019 office visit at Mayo Clinic in Rochester, Minnesota, Phoenix and Scottsdale, Arizona, and Jacksonville, Florida
|Overall rating of care received during your visit
|Likelihood of recommending
|Our sensitivity to your needs
|Your confidence in this care provider
|Care provider's efforts to include you in decisions about your treatment
In a typical year, patients from over 20 countries and 50 U.S. states and territories receive care for multiple myeloma at Mayo Clinic.‡ Mayo Clinic is a leader in multiple myeloma research and analytics, with a focused research database established in the 1960s that continues today.
Patients with multiple myeloma had access to over 35 treatment clinical trials at Mayo Clinic in 2019, including studies across the spectrum of disease, from newly diagnosed multiple myeloma to relapsed and refractory disease. Because Mayo Clinic is a leader in research, patients at Mayo Clinic have access to therapies that are not available elsewhere.
Our myeloma care model is used all over the world with access to new evidence and guidelines via the Mayo Stratification for Myeloma & Risk-Adapted Therapy (mSMART) system, which reaches over 22,000 website visitors from the United States, Japan, China, India, Canada, Brazil and many other countries annually.
‡Office visit or peripheral blood stem cell transplant for multiple myeloma
Access to specialized physicians and scientists
Based on specialized physician count, Mayo Clinic has one of the largest programs in the nation devoted to myeloma care. Our multiple myeloma program has over 40 physicians and researchers dedicated to treating myeloma. Our multidisciplinary team-based care brings together experts who specialize in hematopathology, genetics, radiation oncology, orthopedic oncology, radiology and specialized imaging, interventional radiology, nephrology, bone and neurology. These specialists are internationally recognized leaders in their field, and they work together to determine the best course and sequence of therapy according to your individual needs. This is embedded within an organization that focuses on multidisciplinary team-based care and is home to over 4,000 physicians and scientists. In addition, our laboratory serves health care providers worldwide through genetic testing for patients at other institutions. Mayo Clinic does approximately 6,500 genetic tests for multiple myeloma each year for patients around the world. Mayo Clinic staff are recognized as experts by other laboratories and physicians.
Your care journey with Mayo Clinic doesn't stop when you return home
Mayo Clinic offers remote capability to monitor your case through eConsults with your local providers and telemedicine to your home. Mayo Clinic in Rochester, Minnesota, Phoenix and Scottsdale, Arizona, and Jacksonville, Florida, conducted over 34,000 virtual visits in January 2021 alone. Carry our expertise with you throughout your journey.